MedTrace Logo

Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome

NCT07277257 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2025-12-22

No results posted yet for this study

Summary

This study will evaluate the effect of TRYPTYR in patients with Sjögren's syndrome-related dry eye disease. The goal is to determine whether TRYPTYR can improve symptoms and signs of dry eye in this specific patient population.

Conditions

  • Sjogren Syndrome With Keratoconjunctivitis

Interventions

DRUG

TRYPTYR (Acoltremon ophthalmic solution 0.003%)

Drop to be instilled before and after endpoint measurement.

Sponsors & Collaborators

  • Center For Sight

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-02
Primary Completion
2026-12-31
Completion
2026-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07277257 on ClinicalTrials.gov